Table 1.
Subgroup | NCI SR, n (%) (n = 1023) |
---|---|
Ph-like ALL | 139 (13.6) |
CRLF2-R | 41 (4) |
IGH-CRLF2 | 5 (0.5) |
P2RY8-CRLF2 | 36 (3.5) |
CRLF2-R with JAK-STAT mutation | 14 (1.7) |
CRLF2-R without JAK-STAT mutation | 27 (2.6) |
Non-CRLF2 | 98 (9.6) |
ABL1-class fusions | 2 (0.2) |
JAK2-R | 2 (0.2) |
EPOR-R | 0 |
NTRK3-R | 1 (0.1) |
Other JAK-STAT | 2 (0.2) |
Ras | 6 (0.6) |
No kinase identified | 56 (5.5) |
Not tested | 29 (2.8) |
ABL1-class: ZMIZ1-ABL1, EBF1-PDGFRB. JAK2-R: ETV6-JAK2, PAX5-JAK2. NTRK3: ETV6-NTRK3. Other JAK-STAT: IL7R. Ras: KRAS, NRAS.